AI filing briefs · archive

8-K filings in January 2025, explained

528 material Form 8-K filings that 462 companies we cover made with the SEC in January 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

8 of 528 briefs match

newest first · times in ET
FHNFIRST HORIZON CORP Jan 30, 5:01 PM ET

First Horizon adds Jeffrey J. Brown to board, expands board to 14 members

Neutral leadership Written later 5.025.03

First Horizon Corporation elected Jeffrey J. Brown, former CEO of Ally Financial, to its board on January 27, 2025, and director Harry V. Barton, Jr. said he will retire at the 2025 annual meeting. The board also amended its bylaws to increase its size from 13 to 14 members until that meeting, after which it returns to 13. These are governance changes that do not include reported financial results.

  • Jeffrey J. Brown, age 51, elected to the board effective immediately; he will stand for shareholder election at the 2025 annual meeting and joins the Compensation, Executive, and Risk Committees
  • Harry V. Barton, Jr., age 70, will retire from the board when directors are elected at the 2025 annual meeting, scheduled for April 29, 2025
  • Bylaw Section 3.2 amended effective immediately to set board size at 14 members until the 2025 annual meeting, then 13
Read the filing on SEC.gov ↗
AMTMAmentum Holdings, Inc. Jan 30, 4:21 PM ET

Amentum grants CEO John Heller 1.37 million options and 155,938 RSUs

Neutral leadership Written later 5.02

Amentum's Compensation Committee approved a equity grant to CEO John Heller on January 28, 2025, consisting of 1,373,955 options and 155,938 restricted stock units. The company says the grant is meant to make up value lost when prior equity awards were converted in connection with the transaction that made Amentum a public company.

  • Option award: 1,373,955 options with an exercise price of $22.71, vesting ratably over three years and expiring on the fourth anniversary of the grant date
  • RSU award: 155,938 restricted stock units vesting ratably on the first, second and third anniversaries of the grant date
  • Vesting may accelerate upon qualifying termination of employment
  • Option award agreement filed as Exhibit 10.1; RSU form agreement was previously filed with an 8-K on November 13, 2024
Read the filing on SEC.gov ↗
ADBEADOBE INC. Jan 30, 4:17 PM ET

Adobe's Chief Strategy Officer Scott Belsky to resign effective March 15, 2025

Neutral leadership Written later 5.02

Adobe said Chief Strategy Officer and EVP Scott Belsky will resign effective March 15, 2025, to pursue another career opportunity. The filing also discloses a new 2025 Performance Share Program and a 2025 Executive Annual Incentive Plan for executive officers, with awards tied to relative stockholder return, Net New Sales, revenue and non-GAAP earnings per share.

  • Scott Belsky notified Adobe on January 24, 2025 of his resignation as Chief Strategy Officer and EVP, Design & Emerging Products, effective March 15, 2025.
  • The 2025 Performance Share Program has a three-year Relative TSR Goal (calendar 2025-2027) and a Net New Sales Goal, each weighted 50%, with payouts capped at 200% of target.
  • Chair and CEO Shantanu Narayen has a target Performance Share award of 73,837 shares, with a maximum of 147,674 shares.
  • The 2025 Executive Annual Incentive Plan requires at least 95% of the fiscal 2025 GAAP revenue target and 95% of the non-GAAP diluted EPS target before any bonus is paid.
Read the filing on SEC.gov ↗
CXMSprinklr, Inc. Jan 30, 4:06 PM ET

Sprinklr adds two directors; audit chair Edwin Gillis to step down in 2025

Neutral leadership Written later 5.02

Sprinklr appointed Jan R. Hauser and Stephen M. Ward, Jr. to its board, effective January 29, 2025, expanding the board from eight to ten directors. Audit Committee Chair Edwin Gillis will hand the chair role to Ms. Hauser on March 31, 2025 and leave the board on June 12, 2025, after which the board will have nine directors.

  • Jan R. Hauser appointed as a Class I director and Audit Committee member, effective January 29, 2025
  • Stephen M. Ward, Jr. appointed as a Class II director and Compensation Committee member, effective January 29, 2025
  • Edwin Gillis steps down as Audit Committee Chair effective March 31, 2025, and leaves the board June 12, 2025
  • Company extended Gillis's post-termination option exercise period for vested options until June 12, 2026
Read the filing on SEC.gov ↗
WDCWESTERN DIGITAL CORP Jan 30, 4:01 PM ET

Western Digital names Irving Tan CEO, effective at Sandisk spin-off completion

Neutral leadership Written later 5.02

Western Digital said CEO David Goeckeler will resign, effective upon completion of the spin-off of its flash business, and Irving Tan, currently Executive Vice President of Global Operations, will succeed him as CEO. Goeckeler and two other directors will also leave the board to join Sandisk Corporation, the flash business that will become an independent public company.

  • Irving Tan will become CEO, succeeding David V. Goeckeler, effective upon completion of the Spin-Off; the board made the appointment on January 25, 2025.
  • Tan's base salary will rise to $1,000,000, with a short-term incentive target of 150% of base salary.
  • Tan will receive a promotion equity award with a grant date value of $6,500,000, and his fiscal 2026 annual LTI award is expected to increase to $11,500,000.
  • Directors David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from the board effective with the Spin-Off, and Tan, Bruce Kiddoo and Roxanne Oulman will join it.
Read the filing on SEC.gov ↗
BOHBANK OF HAWAII CORP Jan 30, 2:24 PM ET

Bank of Hawaii grants service-based RSUs to two executives, 7,032 units each

Neutral leadership Written later 5.02

Bank of Hawaii's Human Resources and Compensation Committee awarded service-based restricted stock units on January 24, 2025 to two designated named executive officers, Marco A. Abbruzzese and S. Bradley Shairson, with 7,032 units each. The grants are routine compensation under the company's 2024 Stock and Incentive Plan and do not involve a change in officer roles.

  • Grant date: January 24, 2025, awarded by the Human Resources and Compensation Committee
  • Marco A. Abbruzzese, Vice Chair, Wealth Management: 7,032 RSUs
  • S. Bradley Shairson, Vice Chair and Chief Risk Officer: 7,032 RSUs
  • Grants made under the 2024 Stock and Incentive Plan; form of grant agreement filed as Exhibit 10.1
Read the filing on SEC.gov ↗
EFOREverforth Inc Jan 30, 9:01 AM ET

ASGN President Rand Blazer steps aside March 1; Shiv Iyer named to succeed him

Neutral leadership Written later 5.02

ASGN Incorporated (NYSE: ASGN) said President Rand Blazer will move to Executive Vice Chairman effective March 1, 2025, and will advise on strategic initiatives. Shiv Iyer, a former Accenture consulting executive, will become President as part of a planned succession. The filing does not discuss financial results or compensation changes, and it names ASGN Incorporated, not Everforth Inc (EFOR) as listed in the request.

  • Rand Blazer (75) resigns as President effective March 1, 2025, and becomes Executive Vice Chairman
  • Shiv Iyer, former Americas Consulting and Industry X Lead Executive at Accenture, will become President
  • Blazer and the company amended his employment agreement on January 29, 2025
  • Blazer was named President in 2022 and has been with the company since its 2012 combination with Apex Systems
Read the filing on SEC.gov ↗
LNTHLantheus Holdings, Inc. Jan 30, 8:44 AM ET

Lantheus Appoints Dr. P.K. Morrow, Oncology Executive, to Board of Directors

Neutral leadership Written later 5.02

Lantheus Holdings appointed Phuong Khanh (P.K.) Morrow, M.D., a former pharmaceutical executive focused on oncology, to its board of directors, effective February 1, 2025. The board expanded to eleven directors, nine of whom are independent, and Dr. Morrow will sit on the Science and Technology Committee. The filing describes a board seat, not a change in financial results or guidance.

  • Dr. Morrow was appointed by the board on January 29, 2025 and is effective February 1, 2025.
  • Board size increased to eleven directors; Dr. Morrow is a Class II Director with a term expiring at the 2026 annual meeting.
  • Director compensation: $60,000 annual cash retainer, $7,500 for Science and Technology Committee service, a $100,000 initial grant, and a $400,000 annual equity grant starting in 2025.
  • Dr. Morrow was previously Chief Medical Officer at CRISPR Therapeutics and held roles at Amgen; she currently leads oncology R&D at Takeda.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.